Skip to main content

Call for papers - Diabetic ocular complications

Guest Editor

Padmaja Kumari Rani, MD, L V Prasad Eye Institute, India
Wei Wang, MD, Sun Yat-sen University, China

Submission Status: Open   |   Submission Deadline: 9 August 2024

BMC Ophthalmology is calling for submissions to our Collection, Diabetic ocular complications. We welcome papers exploring diabetic ocular complications ranging from diabetic retinopathy, macular edema , cataracts, glaucoma, and neuro-ophthalmic manifestations.

New Content ItemThis Collection supports and amplifies research related to SDG 3: Good Health & Well-Being

Meet the Guest Editors

Back to top

Padmaja Kumari Rani, MD, L V Prasad Eye Institute, India

Dr Padmaja Kumari Rani is a vitreoretinal surgeon and an expert in the management of diabetic retinopathy with 23 years of professional experience. Dr Rani is currently a faculty of Anant Bajaj Retina Institute, Srimati Kanuri Shanthamma Centre for Vitreoretinal diseases, L V Prasad Eye Institute, Hyderabad (India) and Associate Director of Teleophthalmology. She has over 150 peer reviewed publications. She is the author of Sankara Nethralaya's Atlas of Retina Diseases.

Wei Wang, MD, Sun Yat-sen University, China

Dr Wei Wang is currently the ophthalmologist and assistant researcher at Zhongshan Ophthalmic Center, Sun Yat-sen University, and the member of Neuro Ophthalmology Professional Committee, China Association of Research Hospitals. He gained his Doctoral degree for Ophthalmology in Sun Yat-sen University, and worked as visiting fellow in Center for Eye Research Australia in Melbourne Australia from 2016 to 2017. 
His research focuses on epidemic ophthalmology and imaging. 

About the Collection

BMC Ophthalmology is calling for submissions to our Collection, Diabetic ocular complications. 

Diabetes mellitus is a global health concern that affects millions of individuals worldwide. Its systemic manifestations are well-documented, but its effects on ocular health are equally significant. Diabetic ocular complications encompass a spectrum of conditions, ranging from diabetic retinopathy and macular edema to cataracts, glaucoma, and neuro-ophthalmic manifestations. These complications can result in severe vision impairment and even blindness, posing a significant public health challenge.

As diabetes continues to rise in prevalence worldwide, the burden of diabetic eye diseases is also increasing. Without a deeper comprehension of these complications, we risk compromising the visual well-being and overall quality of life for millions of individuals. Moreover, interdisciplinary research at the intersection of diabetes and ophthalmology has already yielded remarkable breakthroughs. Innovative diagnostic tools, such as optical coherence tomography (OCT) and anti-VEGF therapies, have transformed our ability to detect and manage diabetic retinopathy and macular edema. Looking ahead, the potential for further discoveries in genetics, regenerative medicine, and artificial intelligence-driven diagnostics holds promise for even more effective and personalized treatments. By continuing to advance our knowledge, we can aspire to a future where diabetic ocular complications no longer threaten the vision and livelihood of those affected by diabetes.

This Collection will showcase research exploring diabetic ocular complications, including but not limited to: 

  • Diabetic retinopathy pathogenesis
  • Innovations in diabetic macular edema treatment
  • Neuro-ophthalmic manifestations of diabetes
  • Diabetic keratopathy insights
  • Cataract surgery in diabetic patients
  • Glaucoma risk in diabetic individuals
  • Diabetic eye diseases epidemiology
  • Diabetic retinopathy screening strategies
  • Diabetic macular degeneration therapeutics
  • Novel approaches to managing diabetic ocular complications

This collection supports and amplifies research related to SDG 3: Good Health & Well-Being

Image credit: TefiM / Getty Images / iStock

  1. This study aimed to explore differences in vitreous humour metabolites and metabolic pathways between patients with and without diabetic retinopathy (DR) and identify potential metabolite biomarkers.

    Authors: Jinmeng Liu, Shuang Liu, Peng Hui, Siying Teng, Jinghui Xie and Yabin Sun
    Citation: BMC Ophthalmology 2024 24:270
  2. To evaluate the short-term effects (hours-days) of intravitreal dexamethasone implant (IDI) in eyes with diabetic macular edema (DME) refractory to anti-vascular endothelial growth factor (VEGF) injections.

    Authors: Jazmín Baca Moreno, David Berrones Medina, María Fernanda Rosellón-Escobar and José Gerardo García-Aguirre
    Citation: BMC Ophthalmology 2024 24:113
  3. To find potential relation between retrobulbar vessels and fundus microvessels and to detect sensitive and effective clinical indicators in predicting the progress of diabetic retinopathy (DR), ocular hemodyna...

    Authors: Jin Wei, Chong Chen, Yinchen Shen, Fang Li, Shu Yiyang and Haiyun Liu
    Citation: BMC Ophthalmology 2024 24:76
  4. To study the changes of retinal function in type 2 diabetes mellitus(DM) patients without apparently diabetic retinopathy via multifocal electroretinogram. Methods: Thirty-six type 2 DM patients (72 eyes) with...

    Authors: Rong-Rong Li, Yang Yang, Meng-Ge Zhang, Jie Wang, Hong Chen, Shan Liu, Hui Miao and Yun-Chang Wang
    Citation: BMC Ophthalmology 2024 24:71

Submission Guidelines

Back to top

This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Diabetic ocular complications" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.